Patents Assigned to Societe Valbiofrance
  • Drug and pharmaceutical composition for the treatment of muscles
    Patent number: 5852003
    Abstract: Use of at least one polymer or one biopolymer, called HBGFPP, specifically protecting the growth factors of the FGF and beta TGF families from tryptic degradation in the manufacture of a drug for the treatment of muscular tissues.
    Type: Grant
    Filed: January 3, 1997
    Date of Patent: December 22, 1998
    Assignee: Societe Valbiofrance
    Inventors: Denis Barritault, Jean-Pierre Caruelle, Pascal Desgranges, Jean Gautron, Anne Meddahi
  • Drug and pharmaceutical composition for the treatment of lesions of the digestive tract
    Patent number: 5852004
    Abstract: Use of at least one polymer or one biopolymer, called HBGFPPs, specifically protecting the growth factors of families of FGFs and beta TGFs from tryptic degradation and not significantly inhibiting coagulation, in the manufacture of a drug for the treatment of lesions of the digestive tract and of primary or secondary derived tissues of the endoderm and the mesoderm.
    Type: Grant
    Filed: December 30, 1996
    Date of Patent: December 22, 1998
    Assignee: Societe Valbiofrance
    Inventors: Denis Barritault, Jean-Pierre Caruelle, Anne Meddahi